Iridex Corporation

About Iridex Corporation

Iridex Corporation is a leading provider of innovative laser-based medical devices and solutions for the treatment of eye conditions, specializing in retina and glaucoma care. Celebrating 35 years of innovation, Iridex offers advanced technologies for office-based and operating room settings with a commitment to high-quality, efficient, and versatile treatment options.

Products & Services

Lasers:Includes models like Cyclo G6, OcuLight, IQ 532, and IQ 577 for various ophthalmic treatments.

Retinal Surgical Instruments:Tools such as laser probes and consumables for retinal surgeries.

Glaucoma Devices:Devices like MicroPulse P3, G-Probe, and MicroPulse Laser Trabeculoplasty (MLT) Lens for glaucoma management.

Retina Delivery Devices:Includes LIO and TxCell for precise delivery in retinal treatments.

MicroPulse Technology:Patented Fovea-friendly laser technology for treating common retinal diseases and glaucoma.

PASCAL Laser:Features a patented 4-fiber design and MicroPulse technology for high-volume efficiency.

Vitreoretinal Consumables:Portfolio of consumables for precision surgery in hospital and ASC settings.

ENT and Veterinary Solutions:Specialized laser solutions for ENT and veterinary applications.

Specialties

Ophthalmic Laser Technology Retinal Disease Treatment Glaucoma Management MicroPulse Laser Technology Vitreoretinal Surgery Solutions

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B Preferred Stock and Convertible Notes T: - FT: Series B Preferred Stock and Convertible Notes	A: 10000000 MR: - FA: $10 million FAN: 10000000	D: 2025-03-19 FD: 2025-03-19	1 investors
2	RT: Convertible Note T: - FT: Convertible Note	A: 3500000 MR: - FA: approximately $3.5 million FAN: 3500000	D: 2024-08-05 FD: 2024-08-05	2 investors

Series B Preferred Stock and Convertible Notes Latest

2025-03-19

$10.0M

1 investor (Pro only)

Convertible Note 2024-08-05

$3.5M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

P

Patrick Mercer

Chief Executive Officer and President

Recent News